XML 30 R20.htm IDEA: XBRL DOCUMENT

Stockholders' Equity Transactions

3 Months Ended

Sep. 30, 2025

Stockholders' Equity Transactions

Stockholders' Equity Transactions

NOTE 11 – Stockholders’ Equity Transactions

Dividends

The following tables summarizes information about dividends declared by the Company for the three months ended September 30, 2025 and the fiscal year ended June 30, 2025:


Dividend Declaration Date		Stockholders of Record Date		Dividend Payable Date		Per Share Cash Dividend Amount

October 30, 2025		December 12, 2025		January 2, 2026		$ 0.14
August 21, 2025		September 12, 2025		October 3, 2025		$ 0.14
May 2, 2025		June 12, 2025		July 3, 2025		$ 0.14
January 30, 2025		March 12, 2025		April 3, 2025		$0.125
November 1, 2024		December 12, 2024		January 3, 2025		$0.125
August 22, 2024		September 12, 2024		October 3, 2024		$0.125

Common Share Repurchases

On September 16, 2014 the Company’s board of directors authorized the repurchase of up to 2 million of the approximately 38.8 million shares of the Company’s common stock then outstanding. Such repurchases may be made from time to time in the open market or in privately negotiated transactions subject to market conditions and the market price of the common stock. In December of Fiscal 2018, the board of directors authorized the repurchase of up to an additional 1 million shares. In November of Fiscal 2025, the board authorized the repurchase of up to an additional 1 million shares. During the first quarter of the fiscal year ended June 30, 2025, the Company repurchased 193,252 shares of its outstanding common stock at a weighted average price of $37.67. During the second quarter of the fiscal year ended June 30, 2025, the Company repurchased 282,647 shares of its outstanding common stock at a weighted average price of $37.95. During the third quarter of the fiscal year ended June 30, 2025, the Company repurchased 745,000 shares of its outstanding common stock at a weighted average price of $25.22. Shares repurchased through the fiscal year ended June 30, 2025, are included in the Company’s Treasury Stock as of June 30, 2025. The Company currently has available 359,741 shares that can be repurchased under this authorization.

None of the Company’s common stock was repurchased during the three months ended September 30, 2025. The following tables summarizes information about shares repurchased by the Company for the fiscal year ended June 30, 2025:


						Total Number of		Maximum
		Total				Shares Purchased as		Number of Shares
		Number of		Average		Part of Publicly		that May Yet Be
		Shares		Price Paid		Announced Plans or		Purchased Under
Period		Purchased		per Share		Programs		Plans or Programs
September 10, 2024 - September 19, 2024		193,252		$ 37.67		193,252		1,387,388
November 7, 2024 - December 19, 2024		282,647		$ 37.95		282,647		1,104,741
February 6, 2025 - March 20, 2025		745,000		$ 25.22		745,000		359,741
Total for the 9 months ended March 31, 2025		1,220,899		$ 30.14		1,220,899		359,741

During the three months ended September 30, 2025, certain employees and directors exercised stock options under the Company's 2012 Employee Stock Option Plans totaling 12,000 shares. All of the 12,000 shares exercised were completed as cashless exercises as allowed for under the plans, where the exercise shares are issued by the Company in exchange for shares of the Company's common stock that are owned by the optionees. The number of shares withheld by the Company was 6,576 and was based upon the aggregate fair market value on the date of exercise equal to the purchase price being paid.

During the three months ended September 30, 2024, certain employees and directors exercised stock options under the Company's 2012 Employee and 2020 Non-Employee Stock Option Plans totaling 5,000 shares. Of the 5,000 shares exercised, 3,000 of these exercises were completed as cashless exercises as allowed for under the plans, where the exercise shares are issued by the Company in exchange

for shares of the Company's common stock that are owned by the optionees. The number of shares withheld by the Company was 2,151 and was based upon the aggregate fair market value on the date of exercise equal to the purchase price being paid.